Susceptibility of clinical isolates of multiresistant Pseudomonas aeruginosa to a hospital disinfectant and molecular typing

Memorias do Instituto Oswaldo Cruz

Volumn 100, Issue 5, 2005, Pages 541-548

  Araujo Romão, Célia Maria Carvalho Pereira ^a,b   De Faria, Yaisa Naziozeno ^a   Pereira, Luciana Roberto ^a   Asensi, Marise Dutra ^b  

^a Oswaldo Cruz Foundation   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Disinfectants; Pseudomonas aeruginosa; Pulsed field gel electrophoresis

Indexed keywords

PSEUDOMONAS AERUGINOSA;

EID: 26444444072     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0074-02762005000500015     Document Type: Article

References (48)

1. AFNOR-Association Française de Normalisation 1998. Normes & Réglementation: Antiseptiques et Disinfectants, Paris, 538 pp.
2. Beloian A 1990. Disinfectants. In Official Methods of Analysis, chapter 6, 15th ed., Association of Official Analytical Chemists, Arlington.
3. Bert F, Lambert-Zechovsky N 1999. Résistance aux antibiotiques et problèmes thérapeutiques posés par Pseudomonas aeruginosa. La Presse Medicale 28: 451-458.
4. Chapman JS 2003. Disinfectant resistance mechanisms, cross-resistance, and co-resistance. Int Biodeterior & Biodegr 51: 271-276.
5. Chuanchuen R, Narasaki CT, Schweizer HP 2002. The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of Triclosan. J Bacteriol 184: 5036-5044.
6. Cozad A, Jones RD 2003. Disinfection and prevention of infectious disease. Am J Infect Control 31: 243-254.
7. Engelhart SKL, Glasmacher A, Fischnaller E, Marklein G, Exner M 2002. Pseudomonas aeruginosa outbreak in a haematolgy-oncology unit associated with contaminated surface cleaning equipment. J Hosp Infect 52: 93-98.
8. Fadda G, Spanu T, Ardito F, Taddei C, Santangelo R, Siddu A, Ciccaglione D, The Italian Epidemiological Observatory 2004. Antimicrobial resistance among non-fermentative Gram-negative bacilli isolates from respiratory tracts of Italian inpatients: a 3-year surveillance study by the Italian Epidemiological Survey. Int J Antimicrob Agents 23: 254-261.
9. Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R 2001. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns and molecular typing in global SENTRY Antimicrobial Surveillance Programe, 1997-1999. CID 32 (Suppl. 2): S146-S155.
10. Gales AC, Menezes LC, Silbert S, Sader H 2003. Dissemination in distinct brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase. J Antimicrob Chemoter 52: 699-702.
11. Gaze WH, Abdouslam N, Hawkey PM, Wellington EMH 2005. Incidence of class 1 integrons in a quaternary ammonium compound-polluted environment. Antimicrob Agents Chemother 49: 1802-1807.
12. Grundmann H, Scheider C, Hartung D, Daschner FD, Pitt T 1995. Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J Clin Microbiol 33: 528-534.
13. Harris A, Torres-Vieira C, Venkataraman L, DeGirolami P, Samore M, Carmeli Y 1999. Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Clin Infect Dis 28: 1128-1133.
14. Heir E, Lindstedt BA, Røtterd OJ, Vardund T, Kapperud G, Nesbakken T 2004. Molecular epidemiology and disinfectant susceptibility of Listeria monocytogenes from meat processing plants and human infections. Int J Food Microbiol 96: 85-96.
15. Herruzo-Cabrera R, Vizcaino-Alcaide MJ, Fernández-Aceñero MJ 2004. The influence of laboratory adaptation on test strains, such as Pseudomonas aeruginosa, in the evaluation of the antimicrobial efficacy of ortho-phthalaldehyde. J Hosp Infect 57: 217-222.
16. Higgins CS, Murtough SM, Hiom SJ, Payne DJ, Russell AD, Walsh TR 2001. Resistance to antibiotics and biocides among non-fermenting Gram-negative bacteria. Clin Microbiol Infect Dis 7: 308-315.
17. Hugo WB, Russell AD 1992. Types of antimicrobial agents. In AD Russell, WB Hugo, GAJ Ayliffe (eds), Principles and Practice of Disinfection, Preservation and Sterilization, 2nd ed., Blackwell Science, Oxford, p. 7-88.
18. Jones NJ, Sader HS, Beach ML 2003. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains o nom-fermentative gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001). Int Jour Antimicrob Agents 22: 551-556.
19. Kersulyte D, Struelens MJ, Deplano A, Berg DE 1995. Comparison of arbitrarily primed PCR and macrorestriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients. J Clin Microbiol 33: 2216-2219.
20. Kazama H, Hamashima H, Sasatsu M, Arai T 1998. Distribution of the antiseptic-resistance genes qacE and qacEΔ1 in Gram-negative bacteria. FEMS Microbiol Lett 159: 173-178.
21. Kõljalg S, Naaber P, Mikelsaar M 2002. Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility. J Hosp Infect 51: 106-173.
22. Loureiro MM, Moraes BA, Mendonça VLF, Quadra MRR, Pinheiro GS, Asensi MD 2002. Pseudomonas areuginosa: study of antibiotic resistance and molecular typing in hospital infection cases in a neonateal intensive care unit from Rio de Janeiro City, Brazil. Mem Inst Oswaldo Cruz 97: 387-394.
23. Lycsak JB, Cannon CL, Pier GB 2000. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microb Infect 1051-1060.
24. Mac Bain AJ, Ledder RG, Moore LE, Catrenich CA, Gilbert P 2004. Effects of quaternary-ammonium-based formulation on bacterial community dynamics and antimicrobial susceptibility. Appl Environ Microbiol 70: 3449-3456.
25. Mac Donnell G, Russell AD 1999. Antiseptics and disinfectants: activity, action and resistance. Clin Microbiol Rev 12: 147-179.
26. Martins ST, Moreira M, Furtado GHC, Marino CGJ, Machado FR, Wey SB, Medeiros EAS 2004. Application of control measures for infections caused by multi-resistant Gram-negative bacteria in intensive care unit patients. Mem Inst Oswaldo Cruz 99: 331-334.
27. im-16, and a fused form of aminoglycoside-resistant gene aac(6′)-30/aac(6′) -Ib: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 48: 4693-4702.
28. Murtough SM, Hiom SJ, Palmer M, Russell AD 2001. Biocide rotation in the healthcare setting: is there a case for policy implementation? J Hosp Infect 48: 1-6.
29. NCCLS-National Committee for Clinical Laboratory Standards 2000. Performance Standard for Antimicrobial Disk Susceptibility Tests; Approved Standard, 7th ed., Wayne, PA, NCCLS document M2-A7.
30. Paulsen IT, Littlejohn TG, Rådström P, Sundström L, Sköld O, Swedberg G, Skurray RA 1993. The 3′ conserved segment of integrons contains a gene associated with multidrug resistance to antiseptics and disinfectants. Antimicrob Agents Chemother 37: 761-768.
31. Poole K 2002. Mechanism of bacterial biocide and antibiotic resistance. J Appl Microbiol Symp 92 (Suppl.): 55S-64S.
32. Rhomberg RP, Jones RN, The MYSTIC Program (USA) Study Group 2003. Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from MYSTIC Program (2002) in North America. Diag Microb Infect Dis 47: 365-372.
33. Romão CMA 1996. Desinfecção e esterilizaç ão química. In P Teixeira, S Valle (eds), Biossegurança - Uma Abordagem Multidisciplinar, Fiocruz, Rio de Janeiro, p. 133-162.
34. Römling U, Wingender J, Müller H, Tümmler B 1994. A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol 60: 1134-1138.
35. Ruiz L, Domíngues MA, Ruiz N, Viñas M 2004. Relationship between clinical and environmental isolates of Pseudomonas aeruginosa. Arch Med Res 35: 251-257.
36. Russell AD 1998. Bacterial resistance to disinfectants: present knowledge and future problems. J Hosp Infect 43 (Suppl.): S57-S68.
37. Russell AD 2004. Bacterial adaptation and resistance to antiseptics, disinfectant and presevatives is not a new phenomen. J Hosp Infect 57: 97-104.
38. Rutala WA, Weber DJ 2001. Surface disinfection: should we do it? J Hosp Infect 48: S64-S68.
39. Rutala WA, Weber DJ 2004. The benefits of surface disinfection. Am J Infect Control 32: 226-231.
40. Rutala WA, Stiegel MM, Sarubbi FA, Weber DJ 1997. Susceptibility of antibiotic-susceptible and antibiotic-resistant hospital bacteria to disinfectant. Infect Control Hosp Epidemiol 18: 417-421.
41. Sader HS, Pignatari AC, Leme IL, Burattini RT, Hollis R, Jones R 1993. Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit. Diagn Microbiol Infect Dis 17: 13-18.
42. Silva Filho LVF, Levi JE, Bento CNO, Rodrigues JC, Ramos SRTS 2001. Molecular epidemiology of Pseudomonas aeruginosa infections in a cystic fibrosis outpatient clinic. J Med Microbiol 50: 261-267.
43. Singleton E 2000. Disinfectants. In Official Methods of Analysis, chapter 6, 17th ed., Association of Official Analytical Chemists, Arlington.
44. Talon D, Cailleaux V, Thouverez M, Michel-Briand Y 1996. Discriminatory power and usefullness of pulsed-field gel electrphoresis in epidemiological studies of Pseudomonas aeruginosa. J Hosp Infect 32: 135-145.
45. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrphoresis: criteria for bacterial typing. J Clin Microbiol 33: 2233-2239.
46. Tsakris A, Tassios PT, Polydorou F, Papa A, Malaka E, Antoniadis A, Legakis NJ 2003. Infrequent detection of acquired metallo-β-lactamase among carbapenem-resistant Pseudomonas isolates in a Greek hospital. Clin Microbiol Infect 9: 846-851.
47. Widmer AF, Frei R 1999. Decontamination, disinfection and sterilization. In PR Murray, EJ Baron, MA Pfaller, FG Tenover, RU Yolken (eds), Manual of Clinical Microbiology, 7th ed., American Society of Microbiology, Washington DC, p. 138-159.
48. Zavascki AP, Cruz RP, Goldani LZ 2005. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients. J Hosp Infect 59: 96-101.